(TTI) Tetra Technologies - Ratings and Ratios
Completion Fluids, Additives, Zinc Bromide, Water Management, Flowback Services
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 63.5% |
| Value at Risk 5%th | 96.0% |
| Relative Tail Risk | -8.06% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.53 |
| Alpha | 105.06 |
| CAGR/Max DD | 0.53 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.533 |
| Beta | 1.443 |
| Beta Downside | 2.421 |
| Drawdowns 3y | |
|---|---|
| Max DD | 67.43% |
| Mean DD | 31.13% |
| Median DD | 33.64% |
Description: TTI Tetra Technologies October 24, 2025
Tetra Technologies Inc. (NYSE:TTI) is an energy-services firm headquartered in The Woodlands, Texas, operating through two primary segments: Completion Fluids & Products, which manufactures clear brine fluids, additives, calcium-chloride products and ultra-pure zinc bromide for drilling, completion and battery applications; and Water & Flowback Services, which delivers on-site water management, frac-flowback handling and production-well testing for onshore oil-gas operators across the United States and international basins.
In its most recent fiscal year, TTI reported revenue of roughly $1.2 billion with an operating margin near 12 %, and a backlog of about $300 million that reflects continued demand for water-recycling services in shale plays. The company’s water-reuse rate now exceeds 80 % in its U.S. operations, a metric increasingly valued by regulators and investors focused on ESG compliance. Additionally, sales of zinc-bromide to battery manufacturers have grown at a compound annual rate of ~15 % since 2021, aligning the firm with the broader clean-energy transition.
Key drivers for TTI include oil-price volatility that influences drilling activity, tightening water-use regulations that boost demand for its flowback services, and the expanding market for high-purity chemicals used in grid-scale storage. For a deeper quantitative dive into TTI’s valuation metrics and scenario analysis, the ValueRay platform offers a transparent, data-first toolkit worth exploring.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (122.2m TTM) > 0 and > 6% of Revenue (6% = 37.1m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA 1.73pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 29.19% (prev 25.76%; Δ 3.43pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 74.3m <= Net Income 122.2m (YES >=105%, WARN >=100%) |
| Net Debt (147.4m) to EBITDA (95.8m) ratio: 1.54 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.35 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (134.8m) change vs 12m ago 2.13% (target <= -2.0% for YES) |
| Gross Margin 25.64% (prev 22.01%; Δ 3.63pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 107.0% (prev 123.3%; Δ -16.24pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.15 (EBITDA TTM 95.8m / Interest Expense TTM 18.6m) >= 6 (WARN >= 3) |
Altman Z'' 1.22
| (A) 0.28 = (Total Current Assets 313.9m - Total Current Liabilities 133.3m) / Total Assets 655.2m |
| (B) -0.23 = Retained Earnings (Balance) -148.9m / Total Assets 655.2m |
| (C) 0.10 = EBIT TTM 58.6m / Avg Total Assets 578.2m |
| (D) -0.50 = Book Value of Equity -179.5m / Total Liabilities 359.7m |
| Total Rating: 1.22 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 58.09
| 1. Piotroski 4.50pt |
| 2. FCF Yield 0.52% |
| 3. FCF Margin 1.00% |
| 4. Debt/Equity 0.72 |
| 5. Debt/Ebitda 1.54 |
| 6. ROIC - WACC (= -3.03)% |
| 7. RoE 43.84% |
| 8. Rev. Trend 58.91% |
| 9. EPS Trend 36.30% |
What is the price of TTI shares?
Over the past week, the price has changed by +10.61%, over one month by +20.64%, over three months by +83.26% and over the past year by +122.37%.
Is TTI a buy, sell or hold?
- Strong Buy: 4
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the TTI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8.2 | -5.5% |
| Analysts Target Price | 8.2 | -5.5% |
| ValueRay Target Price | 10.1 | 16.5% |
TTI Fundamental Data Overview November 29, 2025
P/E Trailing = 8.4457
P/S = 1.6795
P/B = 3.5253
P/EG = 0.2
Beta = 1.137
Revenue TTM = 618.8m USD
EBIT TTM = 58.6m USD
EBITDA TTM = 95.8m USD
Long Term Debt = 180.9m USD (from longTermDebt, last quarter)
Short Term Debt = 10.6m USD (from shortTermDebt, last quarter)
Debt = 214.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 147.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.19b USD (1.04b + Debt 214.6m - CCE 67.2m)
Interest Coverage Ratio = 3.15 (Ebit TTM 58.6m / Interest Expense TTM 18.6m)
FCF Yield = 0.52% (FCF TTM 6.20m / Enterprise Value 1.19b)
FCF Margin = 1.00% (FCF TTM 6.20m / Revenue TTM 618.8m)
Net Margin = 19.75% (Net Income TTM 122.2m / Revenue TTM 618.8m)
Gross Margin = 25.64% ((Revenue TTM 618.8m - Cost of Revenue TTM 460.1m) / Revenue TTM)
Gross Margin QoQ = 23.73% (prev 27.75%)
Tobins Q-Ratio = 1.81 (Enterprise Value 1.19b / Total Assets 655.2m)
Interest Expense / Debt = 2.07% (Interest Expense 4.45m / Debt 214.6m)
Taxrate = 48.78% (3.95m / 8.11m)
NOPAT = 30.0m (EBIT 58.6m * (1 - 48.78%))
Current Ratio = 2.35 (Total Current Assets 313.9m / Total Current Liabilities 133.3m)
Debt / Equity = 0.72 (Debt 214.6m / totalStockholderEquity, last quarter 296.7m)
Debt / EBITDA = 1.54 (Net Debt 147.4m / EBITDA 95.8m)
Debt / FCF = 23.78 (Net Debt 147.4m / FCF TTM 6.20m)
Total Stockholder Equity = 278.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 18.66% (Net Income 122.2m / Total Assets 655.2m)
RoE = 43.84% (Net Income TTM 122.2m / Total Stockholder Equity 278.8m)
RoCE = 12.75% (EBIT 58.6m / Capital Employed (Equity 278.8m + L.T.Debt 180.9m))
RoIC = 6.54% (NOPAT 30.0m / Invested Capital 459.1m)
WACC = 9.57% (E(1.04b)/V(1.25b) * Re(11.33%) + D(214.6m)/V(1.25b) * Rd(2.07%) * (1-Tc(0.49)))
Discount Rate = 11.33% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.81%
[DCF Debug] Terminal Value 57.23% ; FCFE base≈6.20m ; Y1≈4.07m ; Y5≈1.86m
Fair Price DCF = 0.18 (DCF Value 23.5m / Shares Outstanding 133.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 36.30 | EPS CAGR: 93.51% | SUE: 0.43 | # QB: 0
Revenue Correlation: 58.91 | Revenue CAGR: 8.42% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.04 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=0.29 | Chg30d=+0.010 | Revisions Net=+1 | Growth EPS=+61.1% | Growth Revenue=+4.5%
Additional Sources for TTI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle